Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Intangibles: 2023-2024

Historic Intangibles for BioLineRx (BLRX) over the last 2 years, with Dec 2024 value amounting to $10.4 million.

  • BioLineRx's Intangibles fell 23.97% to $10.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.4 million, marking a year-over-year decrease of 23.97%. This contributed to the annual value of $10.4 million for FY2024, which is 29.66% down from last year.
  • Per BioLineRx's latest filing, its Intangibles stood at $10.4 million for FY2024, which was down 29.66% from $14.9 million recorded in FY2023.
  • BioLineRx's 5-year Intangibles high stood at $14.9 million for FY2023, and its period low was $10.4 million during FY2024.
  • In the last 2 years, BioLineRx's Intangibles had a median value of $12.7 million in 2023 and averaged $12.7 million.
  • Data for BioLineRx's Intangibles shows a maximum YoY dropped of 29.66% (in 2024) over the last 5 years.
  • BioLineRx's Intangibles (Yearly) stood at $14.9 million in 2023, then fell by 29.66% to $10.4 million in 2024.